Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001108205-25-000046
Filing Date
2025-05-06
Accepted
2025-05-06 08:04:49
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cris-20250331.htm   iXBRL 10-Q 720310
2 EX-31.1 cris-3312025x10qexx311.htm EX-31.1 10805
3 EX-31.2 cris-3312025x10qexx312.htm EX-31.2 10759
4 EX-32.1 cris-3312025x10qexx321.htm EX-32.1 4742
5 EX-32.2 cris-3312025x10qexx322.htm EX-32.2 4705
  Complete submission text file 0001108205-25-000046.txt   4685079

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20250331.xsd EX-101.SCH 39761
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cris-20250331_cal.xml EX-101.CAL 39838
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cris-20250331_def.xml EX-101.DEF 156568
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20250331_lab.xml EX-101.LAB 553256
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20250331_pre.xml EX-101.PRE 358683
66 EXTRACTED XBRL INSTANCE DOCUMENT cris-20250331_htm.xml XML 477410
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30347 | Film No.: 25915319
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)